Hepatisis Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is the functional unit of the liver an dhow does this relate to blood flow/hepatitis

A

Lobule!

Blood enters from the triads, exits from the central vein

Most blood flows into the liver via the portal vein, which collects bloood from the entire GI tract

Remaining blood is oxygenated blood supplied by portal artery (20%)

These vessels continue to bifurcate—> small venues and arterioles ultimately terminating in the sinusoids which are small blood vessels with fenestrated endothelium (ie there are holes) that are lined by hepatocytes

These terminate in the central vein, from which the blood exits. A lobule has a central vein in the center, around which like spokes of a wheel are the portal traits. Each triad has a branch of the portal vein, a branch of the hepatic artery, and a small bile duct (triad)

Blood enters in the triad, flows through the sinusoids to the central vein, then exits the liver

Hepatocellular necrosis around the portal triad, where inflammation occurs not usually infectious because lots of things cause inflammation in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is hepatitis

A

Hepatic inflammation/injury

Hepatic cell necrosis (cell death)

May be acute or chronic; diverse etiologies;

  • bacterial, fungal, parasitic infections
  • immune disorders
  • metabolic diseases
  • lack of perfusion/oxygenation
  • toxic injury (medications, toxins, herbals, alcohol)
  • viral infections

Inflammation is around the portal triads

Many things can cause hepatitis, most not due to viral infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Viral hepatitis

A

Numerous viruses can infect the liver

However the term viral hepatitis is reserved for those viruses that target the liver specifically - they are hepatotropic

Hepatitis viruses are lettered sequentially:

  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • hepatitis D
  • hep E
  • non A/ nonB - old term used for viral hepatitis of unknown origin

While all hepatitis viruses cause hepatitis, the viruses themselves are quite differnet. The severity of their symptoms can vary in frequency and severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Acute Hepatitis -symptoms

A

Frequency nad severity varies with virus

Mechanism is the same: immune-mediated damage to infected hepatocytes

Less specific sx—> more specific sx

Fever fatigue malaise nausea vomiting—> abdominal pain—> right upper quadrant abdominal pain—> hepatomegaly—> jaundice (icteric phase) with dark urine, pale stools, puritus (itchy skin), sclera icterus

Fulminant hepatitis- massive hepatic necrosis leading to death a rare outcome
- HEV causes this most commonly, followed by HAV and less frequently by HBV and HCV

NB hep A, B and C all cause an acute illness characterized by nausea, malaise, jaundice. Symptoms dont distinguish these viruses nor do they tell you that the hepatitis is due to a virus infection eg alcoholic cirrhosis is very common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Jaundice

A

Yellow discoloration of the skin, sclera, and mucus membranes

Sclera icterus (white of the eyes are yellow)

Due to systemic retention of pigmented bilirubin in tissues

Puriritus-itchy skin

You need to know about bilirubin because you can measure it - an important lab test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bilirubin - breakdown product of hemoglobin

A

Conjugated = direct
Unconjugated = indirect
Total bilirubin = direct + indirect

Bilirubin not soluble; binds to albumin aand is transported to the liver

Conjugation occurs in liver, improves solubility

Erythrocytes are destroyed by macrophages in the spleen and bone marrow releasing hemoglobin which is degraded to heme; the globin is metabolized to its constituent amino acids while heme is converted into unconjugated bilirubin in macrophages of the spleen and bone marrow, bound to plasma albumin and transported to the liver

In the liver it is conjugated with glucuronic acid making it water soluble for excretion in the bile

Conjugated is most hepatic causes
Also hemolytic anemia, EHEC, malaria etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bilirubin metabolism and elimination

A

Jaundice can result from increased production, decreased excretion or both

Pre hepatic causes (mostly unconjugated bilirubin, indirect)

  • increased bilirubin production (hemolytic anemia’s)
  • reduced hepatocellular uptake (drugs interferences with transport systems)
  • impaired conjugation (diffuse hepatocellular disease, hepatitis)

Post hepatic causes
(Mostly conjugated bilirubin, direct)

Decreased hepatocellular excretion - Dublin Johnson syndrome

Impaired bile flow
- biliary obstruction

More than one mechanism can operate to produce jaundice

Normally unconjugated bilirubin contributes more to the total serum bilirubin than the conjugated form since the later is produced n the liver and secreted into the bile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In addition to impaired bilirubin metabolism, death of hepatocytes releases various enzymes

A

Serum level of these enzymes (called Liver Function Tests) reflects the severity of disease

Follow LFTs over time to monitor disease progress
- ALT (alanine aminotransferase): more specific for liver abnormalities than other enzyme tests, high ALT suggests viral rather than alcohol hepatitis

  • AST (aspartate aminotransferase): less specific, since AST present in muscle and other tissues, this is a mitochondrial enzyme also present in heart, muscle, kidney and brain and so is less specific for liver disease, in many cases of liver inflammation the ALT and AST activities are elevated in a 1:1 ratio
  • AP (alkaline phosphatase): again less specific, but is indicative of bile cut injury, liver and non liver related disease elevated
  • GT (gamma glutamate transpeptidase: often elevated in those who use alcohol or other liver toxic substances to excess
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Chronic Hepatitis - symptoms

See image of cirrhosis end stage liver slide 13

A

If acute infection isnt cleared, patient may develop chronic hepatitis

Caused only by hep B and C with variable frequency

Can be

  • asymptomatic (chronic p ersistent hepatitis)
  • symptomatic (chronic active hepatitis; CAH)

Can lead to bad outcomes:

  • cirrhosis (refers to the way the liver scars due to damage)
  • hepatocellular carcinoma (malignant cancer, often induced by hepB or C but never A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cirrhosis Liver

13 + 14

A

Bridging fibrosis in core biopsy
- fibrous bands connecting portal triads

As liver becomes cirrhosis it shrinks in size, externally it appears modular and is quite firm to the touch
- shrunken, micronodular, firm to touch

As it becomes cirrhosis, it becomes more difficult to pump blood through it—> elevated portal pressures

Liver cirrhosis- bridging fibrosis (bands of births scar tissue that connect the portal triads

Major cause of cirrhosis are chronic alcohol abuse, hep C, hep B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cirrhosis

A

Rigid non compliant liver results in portal hypertension

Resulting symptoms just follow the anatomy —> increased venous pressure throughout leads to fluid transduction (ascites)

Increased pressure in the portal system: things back up - spleen enlarged, pressure in the venous system is increased and as a result fluid leaks out due to hydrostatic pressure giving rise to ASCITES (fluid in abdominal space)

Other outcomes ar hemorrhoids a nd esophageal varies - engorged veins in the lower esophagus, which if torn can lead to massive and life threatening blood loss since there is nothing to stop the bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Classic presentation of cirrhosis

A

Patient who vomits copious amounts of bright red blood (suggests upper GI tract bleed and this is a medical emergency)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cirrhosis also has metabolic consequences

A

Causes portal hypertension (—> varices, large spleen etc and ascites) and hepatic insufficiency (—> jaundice and hepatic encephalopathy)

Decreased clotting factors: coagulopathy

Decreased glycogen storage: hypoglycemia

Increased ammonia: hepatic encephalopathy (liver is not detoxifying blood insufficiently, you get high ammonia levels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hepatitis A virus

A

RNA picornavirus

  • small
  • RNA positive strand
  • single serotype worldwide
  • nonenveloped - quite stable outside the body
  • acute disease and asymptomatic infection ONLY! No chronicity
  • no cytopathic; symptoms result from immune-mediated destruction of virus infected cells, typical acute infection lifestyle

Spread by fecal oral route only and is acid stable; causes acute infections; infection confers life long immunity; there is a vaccine; infection is usuallly symptomatic, usually self-limited. Damage to the liver is from the immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hep A virus pathogenesis

A

Enters bloodstream through oropharynx, replicates in GI tract then viremia spreads to liver

Virus produced and released into bile, and then shed into stool for about 10 days before symptoms appear

HAV replicates slowly in liver and is not cytopathic

Liver pathology due to immune response directed against virus-infected cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hep A virus: epidemiology

A

Affects 1.4 million worldwide annually

Common cause of acute haptitis

Enteric transmission

  • spread person to person via fecal oral route
  • acquired from contaminated food and water
  • stable in fresh and salt water for long periods: shellfish common source- contaminated water; as filter feeders they concentrate the virus

Infection confers immunity

HAV outbreaks usually originate from a point source (daycare center, water supply, restaurant)

Spreads readily - infected people are contagious before they are symptomatic

Get HAV vaccine before traveling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

HAV infection rates have decreased in the US by > 90% in recent years

Due to vaccine1!!

A

Since children are normally asymptomatic they play an important role in the sprea dof community outbreaks where virus is spread between close contacts

Now most outbreaks are associated with contaminated food

Mechanisms of food borne spread of HAV

1) clean food may be contained by a food handler who is incubating HAV
2) food may be contaminated at its source, eg shellfish harvested from waters contaminated with sewage or crops irrigated with contaminated water

Maternal-fetal Transmission and parenteral Transmission through blood transfusions are NOT major risk factors for HAV transmission (but HBV and HCV are)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Recent HAV outbreaks

A

Frozen strawberries in Virginia

Frozen scallops from the Philippines—> HAV outbreaks in several stages including sushi chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hep A virus; clinical sx

A

Acute self-limited- no chronic infection, no association with cancer; > 80% adults symptomatic

Symptoms occur abruptly 15-50 days post exposure, intensify for 4 - 6 days before icteric (jaundice phase)
- incubation is around 1 month and a duration of around 1 month

Infection usually asymptomatic in children

Hepatomegaly in 80%

Jaundice 70% adults, 15% children

Less common = splenomegaly, rash

Fulminant hepatitis rare 1 - 3 per 100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hep A virus Diagnosis

A

Clinical symptoms/signs, their timing and identification of aknown infected source

Lab findings:
- increase in LFTs/bilirubin

Detect: serum HAV igM

  • enzyme immunoassay
  • 100% with acute HAV
  • remain + for 3 - 6 months

IgG antibodies
- early in convalescence
- prior exposure to HAV (or vaccine)
- remain detectable for decades, 85% of individuals who are infected with HAV have a full clinical and biochemical recovery within 3 months, and all by 6
IgM is gold standard for diagnosing acute infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

HAV Treatment/control

A

Treatment: supportive since HAV is self limited

Full recovery within 3 months most common

Maintenance of sanitary conditions
- handwashing, cooked foods, avoid impure water

HAV vaccine

  • two inactivated HAV vaccines available
  • indications: travel, chronic liver disease
  • recommended for children as routine immunization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

HBV

A

Genome covered by the core antigen (HBcAg) which is surrounded by a lipid envelope and the surface Ag (HBsAg)

  • HBsAg can assemble into subviral particles, not infectious but more common than virus in the blood of infected people

Another viral protein, called E antigen (HbeAg) is secreted from infected cells and can be detected in patient sera

HBsAg forms the basis of the vaccine that you have received

HBV has a partially dsDNA genome
- makes new DNA from viral RNA by using reverse transcriptase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HBV characteristics? Enveloped? Genome?

Dane particle?

A

HBV enveloped (spared by body fluids) with a partially double stranded DNA genome

Has a rather bizarre replication strategy in that it has a reverse transcriptase (RT) but not an integrase

Some drugs that work against HIV1 RT protein also work against the HBV RT protein, such as lumivudine, an NRTI

Viral DNA covered by core antigen HBcAg which in turn is covered by a lipid membrane from which protrudes the viral surface Ag (HBsAg) which can self assemble to form virus-like particles that can be found in the plasma of infected people—> forms the basis of recombinant subunit HBsAg vaccine

Subviral particles are much more common in the serum of patients that the real virus = DANE PARTICLE

24
Q

HBV: what limits the effectiveness of antibodies

A

Presence of high levels of subviral particles since Ab bind to subviral particles and are soaked up

25
Q

HBV epidemiology

A

About 400 million chornically infected worldwide

Between .7 - 1.4 mill chronically infected in US

Parenteral transmission

  • IV drug use
  • sexual transmission
  • health care workers at risk

**major routes of infection are IV drug use and sexual transmission
HBV vaccine has decreased transmission

26
Q

Geographic Distribution of Chronic HBV infection

Why are rates of HBV infection so high?

A

So high because chronic asymptomatic infections, especially in children

In highly endemic areas, hepB is most commonly spread from mother to child at birth (perinatal Transmission) or through horizontal transmission (exposure to infected blood), especially from an infected child to an uninfected child during the first 5 years of life

Development of chronic infection is very common in infants infected from their mothers or before the age of 5 years

27
Q

HBV in the adult: natural history

A

Most ppl infected with HBV (75%) will not even know they were infected - they are asymptomatic and the virus is cleared

What makes HBV different from HAV is that sometimes the immune response does not clear infection; these people now become chronically infected, and usually remain so for the rest of their lives

Chronically asymptomatic - may have flare ups but are generally asymptomatic

Changes of progressing from acute to chronic HBV is primarily determined by the agent at infection
- younger you are, the more likely your immune response will be modest - clear infection and asymptomatic

90% perinatal acquired HBV progress to chronic disease, then 29-50% for HBV between age 1 - 5 years, 5 - 10% for adult acquired HBV infections
- chances of sympatomatic infx increase with time

2 bad outcomes of chronic infection are progressive cirrhosis —> liver failure and hepatocellular carcinoma
- coinfection with HIV, hep C virus, and superinfection with hep D virus can lead to accelerated disease progression

28
Q

HBV clinical manifestations

A

Acute

  • 70% subclinical = unlike hep A
  • longer incubation period (several months) than hepA
  • symptoms improve after 1 - 3 mo

Chronic HBV

  • many pt asympatomatic for years
  • fatigue most common symptom
  • hepatomegaly early in course
  • persistence depends on age at infx
  • may be detected by observing increased LFTs in an asymptomatic person
  • HBV is major cause of hepatocellular carcinoma
29
Q

HBV and hepatocellular carcinoma

A
  • chronic HBV infx increases risk of HCC by > 100 x
  • 80% of all HCC attributable to HBV
  • HCC one of the three most common causes of cancer mortality in the world
  • HBV may induce HCC indirectly by promoting continued liver repair and cell growth in response to tissue damage
  • integration and expression of some viral proteins may also promote tumor development directly by juxtaposing viral promoters next to cellular growth controlling genes (HBV can insert into the chromosome)
30
Q

How do you tell if a patient is HBV infected? HBV serologies- what can you measure and what they mean

A

HBsAg - HBV surface antigen 9part of virus), if positive, patient is acutely or chronically infected

HBeAg - presence of E Ag (another viral protein) is indicative of high levels of infectious virus

Anti-HBsAg IgG - if positive then either vaccinated, infected in the past, or chronically infected if HBsAg also positive

Anti-HBCAg - IgG means that the patient has been infected in the past becuase HBcAg is NOT part of the vaccine; IgM means acute infection

Anti-HBcAg IgM - antigen B core antigen Ig M - detecting IgM that recognizes the core antigen means that the patient is acutely infected with IgM - positive IgM—> acute infection (doesnt predict whether the pt will become chronically infected)

31
Q

HBV diagnosis - acute infection serology

32/59

A

HBsAg comes up first, and can be detected as early as 1 - 2 weeks and as late as 11 or 12 weeks after exposure to HBV

In persons who recover HBsAg is no longer detectable in serum after an avg period of about 3 months

HbeAg is generally detectable in patients with acute infection, in serum correlates with higher titers of HBV and greater infectivity

**diagnosis of acute HBV infx can be made on the basis of detection of IgM class Ab to hep B core antigens (IgM anti HBc) in serum

IgG anti-HBc persists indefinitely as a marker of past infection, presence of antiHBs IgG following acute infection is indicative of recovery and immunity from reinfection
BUT antiHBsAg by itself could mean vaccine

32
Q

HBV diagnosis - chronic infx serology

A

In chronic infx, HBsAg is detected, but. Ab to HBsAg are often negative due to immune tolerance

Both HBsAg and IgG anti-HBc remain persistently detectable, for life

Presence of HBsAg for 6 mo or more —> chronic infection

In addition, a negative test for IgM anti-HBc together with a positive test for HBsAg in a single serum specimen usually indicates that an individual has chronic HBV infection

33
Q

HBV treatment

A

No treatment for acute

Alpha interferon for chronic infx (PEG)

  • suppress HBV replication
  • activates monocytes and macrophages
  • induces antiviral state in uninfected cells
  • younger pt; no HIV; HCV+; certain HBV genotypes
  • significant side effects; flu like Sxs common; psychiatric side effects

Replication blockers for chronic infx

  • HBV has a reverse transcriptase enzyme
  • lamivudine (nucleoside analog)
  • adenovirus (nucleoside analog)
  • drug resistance may arise
  • children, pregnant women; guidelines complicated
34
Q

HBV: prevention/control

A

HBV vaccine

  • subunit vaccine based on HBsAg
  • produced in yeast engineered to express HBsAg
  • 3 doses of vaccine required, injected IM
  • oversall seroconversion rate ~95%
  • response = HBV surface Ab
  • highly effective
35
Q

HCV

A

Flavivirus

Positive strand RNA genome; lipid envelope with E1 and E2 glycoproteins protruding from its surface, these proteins are responsible for binding virus to the surface of hepatocytes via specific receptors and for mediating membrane fusion that allows virus into cells

6 genotypes, many subtypes and isolates based on nucleotide diversity—> implication for therapy

Viral polymerase is error prone and virus replicates at high levels—> genetic diversity and enable virus to evolve resistance to cellular immune response

Parenteral Transmission

Does not integrate (unlike hepB)

36
Q

HCV epidemiology

What type of transmission

What is it the leading cause of

Genotypes

A

3.2 mill infected

85% of new infections become chronic - much more than HBV

HCV leading cause of

  • chronic liver disease
  • cirrhosis
  • liver cancer
  • liver transplantation

Parenteral transmission (like HBV)

  • transfusion of blood products prior to 1992
  • IV drug use; sexual transmission not as frequent as with HBV, less efficient sexual transmission

Six major HCV genotypes - makes a difference for treatment
- type 1 > 2> 3

37
Q

Hep C testing for baby boomers

A

3% of cohort are HCV + and most dont know they are infected

Males 2x as likely to be infected as females

38
Q

HCV Clinical manifestations

A

Symptoms of acute HCV rare

  • malaise nausea, vomiting, abdominal pain
  • jaundice in < 10%
  • fulminant hepatitis following acute infection is rare

Symptoms of chronic HCV non specific

  • fatigue
  • intermittent nausea
  • vague diffuse or RUQ abdominal pain
  • myalgia, arthralgias

Extrahepatic manifestations
- immune complexes - glomerulonephritis, vasculitis

39
Q

HCV natural history

A

Much higher rate of chronic infection than HBV

85% of ppl infected with HCV develop chronic infection, only 15% clear the virus

  • the fact that HCV establishes a chronic, persistent infection so efficiently means that the virus must avoid and or subvert the immune system
  • fact that virus mutates so quickly means it can get ahead of immune response
  • HCV proteins play roles in subverting interferon response

Chronic infx increases risk for development of HCC—> cirrhosis and liver failure

40
Q

Case presentation for HCV

A

IVDA risk factor for HBV, HCV, HIV (IV drug abuse)

Jaundice and elevated LFTs (HAV, HBV, HCV)

IGG positive for HAV (had hav vaccine or HAV in past)

IgG positive for HBV surface antigen but negative for core antigen (has HBV vaccine) and was HCV Ab positive (either had HCV or has had it in the past).. HCV RNA was high (HCV now)

Wait for pt to clear the infection on his own because of major side effects

41
Q

HCV lab diagnosis

A

HCV antibody (do this for screening)

  • enzyme immunoassay
  • contains core and non structural proteins
  • detect Ab within 4 - 10 weeks of infection
  • false (-): immunocompromised pt

HCV viral load (use to monitor treatment)

  • based on PCR techniques
  • quantitative: predict response, monitor
  • qualitative: detects as low as 100 copies/mL
  • virus load does not predict disease progression

HCV Genotype
- done by sequencing; has implications for Tx

42
Q

HCV treatment revolution

Old standard of care vs new standard of care

A

Old standard of care was combo therapy with Peggy lasted (PEG) interferon (IFN) and ribaviron, nucleoside analogue that interferes with HCV nucleic acid synthesis
- significant side effects —> mood disorders, rage, suicidality, insomnia, fatigue, depression, headaches, mania, fever flu-like symptoms

Genotype 1 cure rate (1yr) - 40-50% but.higher for HCV 2, 3, 4 (6 mo)

43
Q

New standard HCV treatment : drugs that target viral enzymes

A

Recommended for all pt with chronic HCV infx except those with short life expectancies due to comorbidities conditions

Sample drug regimens; treat only 12 weeks, response rates > 90%
Treatment Hx of pt (=/- cirrhosis, drug resistance, HCV genotype can impact choice)

HCV antivirals are highly effective and IFN treatment is becoming a thing of the past

Treat with combos of the drugs for only 12 weeks without interferon basically cures!! Vast majority of SVRs sustained for atleast 5 yrs so HCV can be cured!

44
Q

Hep D virus

A

Delta agent

Small RNA genome that produces only one protein
- single stranded circular RNA surrounded by delta antigen (coded for by the virus) which is surrounded by lipid membrane and HBV surface Ag

Requires HBV surface Ag to p a kale its genome - doesn’t have its own sAG

HDV can only establish an infection in people who are already HBV positive ***

Coinfection with HBV - usually recover

Superinfection with HDV- get HBV get better then get worse! - greatly increases risk of fulminant hepatitis and HCC

45
Q

Hep D pathogenesis and immunity

A

Similar to HBV
- parenteral exposures most efficient

  1. Coinfection ina high acute coinfection with both HBV and HDV occurs, clinically indistinguishable from acute HBV infection and outcome is recovery
  2. Superinfection - HDV infects person who is already chronically infected with HBV, progression to chronic HDV infx usually results, HBV replication is suppressed by HDV, usually the dominant of the 2 viruses
46
Q

Hep D epidemiology

A

5% of HBV infected individuals duality infected with HDV< higher rates outside US

IVDA major mode of transmission (as for HBV and HCV)

47
Q

Hep D clinical disease

A

Once chronic HDV infx established—> rapid progression of liver disease

Cirrhosis in 15% within 1 - 2 yrs of disease onset

Chronic HDV increase risk of hepatocellular carcinoma

Clinical symptoms and signs of acute HDV infx are similar to those seen with other forms of acute viral hepatitis—> malaise fatigue anorexia, nausea, vomiting and abdominal pain

Jaundice and hepatomegaly identified on physical exam… HDV makes everything worse!

48
Q

Hep D ELISA assays

A

Detect Ab and PCR to detect viral RNA

49
Q

Hep D treatment and prevention

A

Nada

50
Q

Hep E virus

A

Non enveloped RNA virus that is rare in US

Endemic in other parts of the world

Acute self limited viral hepatitis, doesnt lead to chronic infx

Mortality rates low but this is still higher than what is seen with HAV (with which it shares most in common with clinically)

Important: HEV infx in a pregnant woman carries with it a 20% mortality

51
Q

HEV diagnosis

A

IgM detected 1 - 4 weeks after the onset of disease, whereas HEV igG can be detected 2 - 4 weeks after disease onset

52
Q

HEV EPi

A

Highest incidence of HEV infection in Asia, Africa, Middle East and Central America

  • transmitted from mother to newborn with substantial perinatal morbidity and mortality
  • only sporadic cases in western countries and these have been linked to travel from endemic areas
53
Q

HEV clinical disease

A

Self limited acute viral hepatitis, lasting 1 - 4 weeks, not progress to chronic disease

Incubation period is 15 - 60 days

Clinical symptoms and signs of acute
HEV infx are similar to those seen with other forms of acute viral hepatitis

May be asymptomatic or may cause hepatitis
- malaise, fatigue, anorexia, nausea, vomiting, abdominal pain

Fulminant hepatitis can occur more frequently in pregnancy (3rd trimester)

NO Treatment except supportive

54
Q
45 yr old pt suspected of having hep 
Lab tests
HBsAg - positive
Anti-HAV IgG - positive
AntiHAV IgM — negative 
Anti HBs IgG - negative
AntiHBc IgM positive
A

This suggests he has a primary infection with HBV now and has had HAV in the past, could have had the HAV vaccine as well

55
Q

Lab tests performed for a 22 yr old farmer who has not been feeling well for the past 3 months show high levels of aspartate transaminase, leukopenia, and decreased serum albumin

Most likely diagnosis is:

A

Hep A - elevated LFTs, decreased albumin which is made in the liver, lengthy time are all consistent with a hepatic process

56
Q

How would you interpret the following serology markers for HBV?

+ HBsAg
+ IgG Anti-HBc
+ IgM Anti HBc
- HBs IgG

A

+ HBsAg - person is infected- doesnt tell you if the infection is acute or chronic

+ IgG Anti-HBc - by itself, means the person is currently infected or has cleared the infection

+ IgM Anti HBc- IgM positivity ALWAYS means acute infection- this trumps everything

  • HBs IgG - IgM to core comes up first - then IgG to core, then IgG to HBsAg. In chronic infection don’t have IgG to HBsAg, if this were positive it would not change anything.. patient is acutely infected; IGG has not developed yet
57
Q

Which of the following is least likely to result in symptoms during acute infection and which is most likely ot result in symptoms

Hep A
B
C
D
E
A

Hep A- maybe 70% in adults but much less in kids- most likely to cause symptoms

B- 25039% symptomatic

C- acute symptoms rare

D- cant cause acute infection on its own

E- probably more than 50% adults symptomatic

Acute: A > B> C
Chronic C> B> A (A doesnt cause chronic)